Talphera Inc TLPH:NASDAQ

RT Quote | USD
Last | 04/23/24 EDT
0.97UNCH (UNCH)
Volume
32,549
52 week range
0.43 - 1.61
Loading...
  • Open0.97
  • Day High1.05
  • Day Low0.95
  • Prev Close0.9459
  • 52 Week High1.61
  • 52 Week High Date02/16/24
  • 52 Week Low0.43
  • 52 Week Low Date11/14/23

Key Stats

  • Market Cap16.46M
  • Shares Out16.97M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.49
  • YTD % Change31.97

KEY STATS

  • Open0.97
  • Day High1.05
  • Day Low0.95
  • Prev Close0.9459
  • 52 Week High1.61
  • 52 Week High Date02/16/24
  • 52 Week Low0.43
  • 52 Week Low Date11/14/23
  • Market Cap16.46M
  • Shares Out16.97M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.49
  • YTD % Change31.97

RATIOS/PROFITABILITY

  • EPS (TTM)-0.73
  • P/E (TTM)-1.33
  • Fwd P/E (NTM)-1.08
  • EBITDA (TTM)-16.578M
  • ROE (TTM)-57.28%
  • Revenue (TTM)651,000.023
  • Gross Margin (TTM)-17.68%
  • Net Margin (TTM)-1,580.18%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Talphera Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Talphera, Inc., formerly AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Niyad is focused on developing regional anticoagulants for injection into the extracorporeal circuit, such as the dialysis circuit during continuous renal replacement therapy (CRRT) for acute...
Adrian Adams
Independent Chairman of the Board
Vincent Angotti
Chief Executive Officer, Director
Raffi Asadorian
Chief Financial Officer
Address
1850 Gateway Drive, Suite 175
San Mateo, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
KALA
KALA BIO Inc
6.40UNCHUNCH
TXMD
TherapeuticsMD Inc
1.92UNCHUNCH
AVTX
Avalo Therapeutics Inc
14.20UNCHUNCH
SEEL
Seelos Therapeutics Inc
0.301UNCHUNCH
GTBP
GT Biopharma Inc
3.65UNCHUNCH